Macrovascular Complications of Type 2 Diabetes Mellitus.
Viigimaa M, Sachinidis A, Toumpourleka M, Koutsampasopoulos K, Alliksoo S, Titma T.
Curr Vasc Pharmacol. 2020;18(2):110-116. doi: 10.2174/1570161117666190405165151.
Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses.
Nanayakkara N, Curtis AJ, Heritier S, Gadowski AM, Pavkov ME, Kenealy T, Owens DR, Thomas RL, Song S, Wong J, Chan JC, Luk AO, Penno G, Ji L, Mohan V, Amutha A, Romero-Aroca P, Gasevic D, Magliano DJ, Teede HJ, Chalmers J, Zoungas S.
Diabetologia. 2021 Feb;64(2):275-287. doi: 10.1007/s00125-020-05319-w. Epub 2020 Dec 14.
Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.
Beckman JA, Creager MA, Libby P.
JAMA. 2002 May 15;287(19):2570-81. doi: 10.1001/jama.287.19.2570.
Preventing foot ulcers in patients with diabetes.
Singh N, Armstrong DG, Lipsky BA.
JAMA. 2005 Jan 12;293(2):217-28. doi: 10.1001/jama.293.2.217.
Limb and cardiovascular event risk in type 1 and 2 diabetic patients with peripheral artery disease.
Sykora D, Firth C, Girardo M, Tseng A, Wennberg P, Liedl D, Shamoun F.
Vasa. 2023 Sep;52(5):310-316. doi: 10.1024/0301-1526/a001086. Epub 2023 Jul 31.
Impact of microvascular complications on the outcomes of diabetic foot in type 2 diabetic patients with documented peripheral artery disease.
Gazzaruso C, Montalcini T, Gallotti P, Ferrulli A, Massa Saluzzo C, Pujia A, Luzi L, Coppola A.
Endocrine. 2023 Apr;80(1):71-78. doi: 10.1007/s12020-022-03291-6. Epub 2022 Dec 24.
Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. UK Prospective Diabetes Study Group.
UK Prospective Diabetes Study Group.
BMJ. 1998 Sep 12;317(7160):703-13.
The Relationship between Muscle Ultrasound Parameters and Diabetic Peripheral Neuropathy among Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study.
Zhong Y, Liu X, Lin T.
J Diabetes Res. 2023 Dec 19;2023:8897065. doi: 10.1155/2023/8897065. eCollection 2023.
Cardiovascular Effectiveness and Safety of Antidiabetic Drugs in Patients with Type 2 Diabetes and Peripheral Artery Disease: Systematic Review.
Cimellaro A, Cavallo M, Mungo M, Suraci E, Spagnolo F, Addesi D, Pintaudi M, Pintaudi C.
Medicina (Kaunas). 2024 Sep 20;60(9):1542. doi: 10.3390/medicina60091542.
Liraglutide improves peripheral perfusion and markers of angiogenesis and inflammation in people with type 2 diabetes and peripheral artery disease: An 18-month follow-up of a randomized clinical trial.
Caruso P, Maiorino MI, Longo M, Maio A, Scappaticcio L, Di Martino N, Carbone C, Barrasso M, Caputo M, Gicchino M, Bellastella G, Giugliano D, Esposito K.
Diabetes Obes Metab. 2025 Jul;27(7):3891-3900. doi: 10.1111/dom.16419. Epub 2025 Apr 25.
